SCHEMBL22200792

SCHEMBL22200792

Cc1nc(NSCCC(F)(F)F)ccc1-c1nc2cnc(N)nc2n(C(C)C)c1=O

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MTOR P42345 9/20 0.35
RORC P51449 3/20 0.35
PIK3CA P42336 5/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22200825 0.84 CYP1A2 (0.36) MTORRORC
SCHEMBL25034224 0.84 RORC (0.38) MTORRORCPIK3CA
SCHEMBL22200393 0.81 RORC (0.34) MTORRORCPIK3CA
SCHEMBL22200653 0.80 MTOR (0.38) MTORRORCPIK3CA
SCHEMBL22200817 0.80 MTOR (0.40) MTORRORCPIK3CA
SCHEMBL22200574 0.79 ERN1 (0.34) MTORRORC
SCHEMBL22200719 0.79 ERN1 (0.42) MTORRORCPIK3CA
SCHEMBL22200355 0.79 ERN1 (0.41) MTORRORCPIK3CA
SCHEMBL22200424 0.78 MTOR (0.37) MTORRORCPIK3CA
SCHEMBL22200818 0.78 MTOR (0.36) MTORRORCPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020142612-A1 PYRIDO-PYRIMIDINONE AND PTERIDINONE COMPOUNDS AS INHIBITORS OF ENDORIBONUCLEASE INOSITOL REQUIRING ENZYME I (IRE I ALPHA) FOR THE TREATMENT OF CANCER DISEASES. GENENTECH, INC. (US) 2020-07-09 WO disclosed